Cell Block Biopsy of Portal Vein Thrombosis for Liver Pre-Transplantation Evaluation

1. Abstract Major vessel invasion in patients with hepatocellular carcinoma (HCC) receiving living donor liver transplantation (LDLT) is one of the major factors for HCC recurrence. Malignant portal vein thrombosis (MPVT) is an absolute contraindication for liver transplantation (LT). DOI:http://dx.doi.org/10.47829/ACMCR.2021.7502